In addition to the direct health benefits, lower heath care utilization, and higher productivity associated with weight loss, other potential benefits of GLP-1 agonists on society include lower spending or demand for groceries and food
Microdosing GLP1 in Menopause & Perimenopause What it is : Microdosing GLP-1 in menopause and perimenopause means using a lower, personalized dose of GLP-1 medication to gently support appetite control, energy, and focus
Its important to talk to your healthcare provider about all the medications youre taking so you can understand how they might affect your body weight
In the STEP 1 clinical trial (NEJM, 2021), participants on semaglutide 2.4 mg lost an average of 14.9% of body weight at 68 weeks (about 33.6 lbs from a 232 lb average baseline) vs 2.4% with placebo
If you notice dark or black stools whilst taking Ozempic, it is essential to consider the full clinical context, including other medications, dietary intake, and accompanying symptoms
Pick a clean, well-lit surface where you can focus without distractions
